PRACTICAL SYNTHETIC PROCEDURES
Cobalt-Catalyzed Cross-Coupling Reactions
1589
IR (Zn/Se-ATR, neat): 2954, 1491, 1451, 1318, 1160, 1138, 1113,
1063, 1034, 765 cm–1.
13C NMR (100 MHz, CDCl3): δ = 24.5, 25.7, 29.4, 29.6, 29.7, 30.2,
30.6, 32.7, 44.2, 63.0.
1H NMR (400 MHz, CDCl3): δ = 0.91 (s, 9 H), 1.35 (m, 2 H), 1.58
(m, 2 H), 2.42 (t, J = 6.9 Hz, 2 H), 7.34 (t, J = 7.3 Hz, 1 H), 7.44 (t,
J = 7.3 Hz, 1 H), 7.52 (d, J = 7.3 Hz, 1 H), 7.61 (d, J = 7.3 Hz, 1 H).
MS (CI): m/z (%) = 227 (31) [M–H]+, 211 (100), 171 (6), 155 (13),
141 (14), 127 (16), 113 (14).
HRMS (CI): m/z [M–H]+ calcd for C15H31O: 227.2375; found:
227.2373.
13C NMR (100 MHz, CDCl3): δ = 20.4, 23.7, 29.3, 30.2, 43.3, 76.7,
96.8, 122.3, 125.0, 125.6, 127.1, 131.2, 131.3, 133.9.
19F NMR (376 MHz, CDCl3): δ = –62.4.
MS (EI): m/z (%) = 268 (27) [M]+, 253 (21), 211 (46), 202 (10), 197
(8), 187 (21).
HRMS (EI): m/z [M]+ calcd for C16H19F3: 268.1439; found:
268.1437.
N-(6,6-Dimethylheptyl)piperidin-2-one (5h)
According to P1, N-(5-iodopentyl)piperidin-2-one (4h) (295 mg,
1.0 mmol) and t-BuMgCl (2a) (0.81 M in THF, 1.2 mmol) were re-
acted under standard conditions. After aqueous work-up, purifica-
tion by flash column chromatography (hexane–EtOAc, 20:1)
afforded the title compound.
Yield: 151 mg (67%); yellow oil.
1-[(tert-Butyldimethylsilyl)oxy]-4,4-dimethylpentane (5e)
According to P1, 1-bromo-3-[(tert-butyldimethylsilyl)oxy]propane
(4e) (253 mg, 1.0 mmol) and t-BuMgCl (2a) (0.81 M in THF, 1.2
mmol) were reacted under standard conditions. After aqueous
work-up, purification by GPC (with CHCl3 as the eluent) afforded
the title compound.
IR (Zn/Se-ATR, neat): 2933, 2861, 1644, 1494, 1468, 1448, 1418,
1353, 1329, 1301, 1176, 972 cm–1.
1H NMR (400 MHz, CDCl3): δ = 0.86 (s, 9 H), 1.17–1.28 (br m, 6
H), 1.54 (m, 2 H), 1.73–1.85 (br m, 4 H), 2.37 (t, J = 6.4 Hz, 2 H),
3.27 (t, J = 6.2 Hz, 2 H), 3.34 (t, J = 7.8 Hz, 2 H).
Yield: 174 mg (76%); yellow oil.
13C NMR (100 MHz, CDCl3): δ = 21.4, 23.2, 24.3, 27.1, 27.8, 29.3,
30.2, 32.3, 44.1, 47.2, 47.8, 169.5.
MS (EI): m/z (%) = 225 (16) [M]+, 220 (15), 205 (7), 167 (59), 153
IR (Zn/Se-ATR, neat): 2953, 2893, 2858, 1471, 1253, 1100, 1006,
940, 834, 814, 773 cm–1.
(18), 139 (8).
1H NMR (400 MHz, CDCl3): δ = 0.10 (s, 6 H), 0.92 (s, 9 H), 0.94
(s, 9 H), 1.21 (m, 2 H), 1.53 (m, 2 H), 3.62 (t, J = 6.8 Hz, 2 H).
HRMS (EI): m/z [M]+ calcd for C14H27NO: 225.2093; found:
225.2091.
13C NMR (100 MHz, CDCl3): δ = –5.2, 18.4, 26.0, 28.2, 29.4, 30.0,
39.9, 64.2.
N,N-Diethyl-7,7-dimethyloctanamide (5i)
MS (EI): m/z (%) = 230 (11) [M]+, 215 (42), 200 (36), 185 (35), 173
(84), 170 (19), 158 (9), 116 (21).
HRMS (EI): m/z [M]+ calcd for C13H30OSi: 230.2066; found:
230.2066.
According to P1, 6-bromo-N,N-diethylhexanamide (4i) (250 mg,
1.0 mmol) and t-BuMgCl (2a) (0.81 M in THF, 1.2 mmol) were re-
acted under standard conditions. After aqueous work-up, purifica-
tion by flash column chromatography (hexane–EtOAc, 20:1)
afforded the title compound.
2-[(5,5-Dimethylhexyl)oxy]tetrahydro-2H-pyran (5f)
Yield: 167 mg (73%); yellow oil.
According to P1, 2-(4-bromobutoxy)tetrahydro-2H-pyran (4f) (237
mg, 1.0 mmol) and t-BuMgCl (2a) (0.81 M in THF, 1.2 mmol) were
reacted under standard conditions. After aqueous work-up, purifica-
tion by GPC (with CHCl3 as the eluent) afforded the title compound.
IR (Zn/Se-ATR, neat): 2934, 2866, 1648, 1465, 1428, 1363, 1260,
1143, 1081, 946 cm–1.
1H NMR (400 MHz, CDCl3): δ = 0.86 (s, 9 H), 1.11 (t, J = 7.4 Hz,
3 H), 1.17 (t, J = 7.4 Hz, 3 H), 1.17–1.28 (m, 6 H), 1.65 (m, 2 H),
2.28 (t, J = 7.8 Hz, 2 H), 3.30 (q, J = 7.4 Hz, 2 H), 3.37 (q, J = 7.4
Hz, 2 H).
13C NMR (100 MHz, CDCl3): δ = 13.1, 14.4, 24.4, 25.5, 29.4, 30.2,
30.4, 33.1, 40.0, 41.9, 44.0, 172.3.
MS (EI): m/z (%) = 227 (18) [M]+, 212 (14), 198 (10), 170 (62), 169
(7), 155 (11).
Yield: 196 mg (91%); colorless oil.
IR (Zn/Se-ATR, neat): 2941, 2868, 1475, 1137, 1120, 1078, 1036,
988, 906, 870, 816 cm–1.
1H NMR (400 MHz, CDCl3): δ = 0.87 (s, 9 H), 1.17–1.23 (m, 2 H),
1.27–1.37 (m, 2 H), 1.49–1.62 (m, 5 H), 1.67–1.77 (m, 1 H), 1.79–
1.87 (m, 1 H), 3.39 (dd, J = 16.5, 6.8 Hz, 1 H), 3.47–3.54 (m, 1 H),
3.75 (dd, J = 16.5, 6.8 Hz, 1 H), 3.84–3.93 (m, 1 H), 4.58 (t, J = 7.3
Hz, 2 H).
HRMS (EI): m/z [M]+ calcd for C14H29NO: 227.2249; found:
227.2242.
13C NMR (100 MHz, CDCl3): δ = 19.7, 21.2, 25.5, 29.4, 30.3, 30.6,
30.8, 44.0, 62.3, 67.7, 98.8.
MS (CI): m/z (%) = 215 (21) [M + H]+, 200 (15), 158 (71), 144 (10),
130 (6).
HRMS (CI): m/z [M + H]+ calcd for C13H27O2: 215.2011; found:
215.2015.
N-(7,7-Dimethyloctanoyl)morpholine (5j)
According to P1, N-(6-bromohexanoyl)morpholine (4j) (264 mg,
1.0 mmol) and t-BuMgCl (2a) (0.81 M in THF, 1.2 mmol) were re-
acted under standard conditions. After aqueous work-up, purifica-
tion by flash column chromatography (hexane–EtOAc, 15:1)
afforded the title compound.
12,12-Dimethyltridecan-1-ol (5g)
Yield: 183 mg (76%); pale yellow oil.
According to P1, 11-bromoundecan-1-ol (4g) (251 mg, 1.0 mmol)
and t-BuMgCl (2a) (1.04 M in THF, 2.5 mmol) were reacted under
standard conditions. After aqueous work-up, purification by flash
column chromatography (hexane then Et2O) afforded the title com-
pound.
IR (Zn/Se-ATR, neat): 2953, 2860, 1651, 1461, 1430, 1272, 1242,
1119, 1035, 962, 851 cm–1.
1H NMR (400 MHz, CDCl3): δ = 0.86 (s, 9 H), 1.16–1.30 (br m, 6
H), 1.66 (m, 2 H), 2.31 (t, J = 7.8 Hz, 2 H), 3.46–3.76 (br m, 8 H).
Yield: 201 mg (88%); colorless oil.
13C NMR (100 MHz, CDCl3): δ = 24.3, 25.3, 29.4, 30.2, 30.4, 33.1,
41.8, 44.0, 46.0, 66.7, 66.9, 171.9.
MS (EI): m/z (%) = 241 (20) [M]+, 226 (13), 184 (65), 170 (9), 155
(9).
IR (Zn/Se-ATR, neat): 3400, 2925, 2854, 1466, 1363, 1056 cm–1.
1H NMR (400 MHz, CDCl3): δ = 0.86 (s, 9 H), 1.14–1.31 (m, 18 H),
1.57 (quin, J = 7.2 Hz, 2 H), 3.64 (t, J = 7.2 Hz, 2 H).
© Georg Thieme Verlag Stuttgart · New York
Synthesis 2014, 46, 1583–1592